Under bill, patients in Nebraska would be informed that stem cell therapies aren’t approved

By Julie Anderson, Omaha World Herald, January 20, 2022 A measure slated for a Friday hearing in the Nebraska Legislature would make sure patients seeking ...

By |January 20th, 2022|

Unapproved Stem Cell Therapies

Yesterday, State Senator John Arch introduced a bill requiring providers to notify patients if they are offering a stem cell treatment that is not FDA ...

By |January 7th, 2022|

From the Desk of the President – Update on Stem Cell Clinics

By David Crouse, PhD In the fall of 2019 edition of this newsletter, I provided an update on the problems with “direct-to-consumer marketing” of stem ...

By |May 18th, 2021|

New FDA Consumer Alert on Stem Cell and Exosome Products

The US Food and Drug Administration (FDA) has authority to regulate regenerative medicine products, including stem cell products and exosome products. There is a lot ...

By |July 28th, 2020|
  • Kris Boesen, CIRM spinal cord injury clinical trial patient.

Young man with spinal cord injury regains use of hands and arms after stem cell therapy

Hope is such a fragile thing. We cling to it in bad times. It offers us a sense that we can bear whatever hardships we ...

By |September 14th, 2016|